Effects of Different Remineralization Agents on the Progression of Non-Cavitated Approximal Carious Lesions in Primary Teeth: A Randomized Clinical Trial
REMİN-PRİMARY
2 other identifiers
interventional
90
1 country
1
Brief Summary
Dental caries is a highly prevalent disease in children. Contemporary caries management emphasizes minimally invasive approaches that aim to arrest or reverse non-cavitated lesions rather than remove tooth structure. This randomized clinical trial aims to evaluate the effects of different remineralization agents on the progression of non-cavitated approximal carious lesions in primary teeth. The study will be conducted in children aged 4-10 years presenting with non-cavitated approximal carious lesions in primary molars. Participants will be randomly assigned to treatment groups receiving silver diamine fluoride (SDF), a self-assembling peptide (P11-4), and/or 5% sodium fluoride (NaF) varnish. Materials will be applied according to manufacturers' instructions. Lesion progression will be assessed using standardized bitewing radiographs obtained at baseline and follow-up visits. Radiographic evaluations will be performed by blinded investigators. In addition, potential tooth color changes associated with the treatments will be quantitatively measured using a spectrophotometer based on the CIE Lab\* system at predefined follow-up intervals. The findings of this study are expected to provide clinically relevant evidence regarding the effectiveness and aesthetic outcomes of contemporary non-invasive caries management strategies in primary teeth.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2025
CompletedFirst Submitted
Initial submission to the registry
February 11, 2026
CompletedFirst Posted
Study publicly available on registry
February 24, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2026
February 24, 2026
February 1, 2026
1.2 years
February 11, 2026
February 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Radiographic progression of approximal caries lesions
Lesion progression will be assessed using standardized bitewing radiographs and evaluated according to the E0-E2, D1-D3 radiographic scoring system. Changes in lesion status over time will be categorized as regression, stability, or progression based on predefined radiographic criteria.
6 months and 12 months after intervention
Secondary Outcomes (2)
Tooth color change (ΔE)
3 months, 6 months, and 12 months
Clinical lesion activity
3 months, 6 months, and 12 months
Study Arms (3)
P11-4 + NaF Varnish
EXPERIMENTALApproximal carious lesions in primary teeth that were non-cavitated were treated with the self-assembling peptide P11-4, followed by 5% sodium fluoride varnish, using a randomized split-mouth design.
Silver Diamine Fluoride
EXPERIMENTALThis study examined the treatment of non-cavitated approximal carious lesions in primary teeth with silver diamine fluoride using a randomized split-mouth design.
NaF Varnish Alone
ACTIVE COMPARATORApproximal carious lesions in primary teeth that were non-cavitated were treated with 5% sodium fluoride varnish alone in a randomized split-mouth design.
Interventions
Topically apply the self-assembling peptide P11-4 (Curodont Repair, Vardis, Switzerland) to non-cavitated approximal carious lesions in primary teeth, followed by 5% sodium fluoride varnish (Profluorid Varnish, VOCO, Germany).
Topical application of silver diamine fluoride (Riva Star, SDI, Victoria, Australia) to non-cavitated approximal carious lesions in primary teeth.
Topical application of 5% sodium fluoride varnish (Profluorid Varnish, VOCO, Germany) was used on non-cavitated approximal carious lesions in primary teeth.
Eligibility Criteria
You may qualify if:
- Children aged 4-10 years
- Presence of at least two non-cavitated proximal caries lesions in primary teeth
- Radiographic detection of lesions classified as E1, E2, or D1
- Absence of systemic disease
- Cooperative patients
- Written informed consent obtained from parents or legal guardians
You may not qualify if:
- Presence of restorations on study teeth
- Deep dentin caries (D2 or D3)
- Cavitated lesions
- Uncooperative patients
- Inability to attend follow-up visits
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Izmir Katip Çelebi University Faculty of Dentistry
Izmir, İzmir, 35640, Turkey (Türkiye)
Related Publications (1)
Anusavice KJ. Present and future approaches for the control of caries. J Dent Educ. 2005 May;69(5):538-54.
PMID: 15897335BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Merve Akçay, Prof. Dr.
Izmir Katip Çelebi University Faculty of Dentistry
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- In this split-mouth randomized clinical trial, the outcome assessor was blinded to the lesions' allocation to remineralization agents.
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Department of Pedodontics
Study Record Dates
First Submitted
February 11, 2026
First Posted
February 24, 2026
Study Start
October 1, 2025
Primary Completion (Estimated)
November 30, 2026
Study Completion (Estimated)
December 30, 2026
Last Updated
February 24, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
Due to institutional policies and ethical considerations regarding pediatric patient confidentiality, individual participant data (IPD) will not be shared.